Research analysts who have asked questions during Theratechnologies earnings calls.
Recent press releases and 8-K filings for THTX.
Theratechnologies Completes Acquisition by Future Pak
THTX
M&A
Delisting/Listing Issues
Takeover Bid
- Theratechnologies Inc. announced the completion of its acquisition by CB Biotechnology, LLC, an affiliate of Future Pak, LLC, on September 25, 2025.
- Shareholders received US$3.01 per Share in cash plus one contingent value right (CVR) per Share.
- Each CVR has a fair market value of US$0.80 as of September 24, 2025, and entitles the holder to additional aggregate cash payments of up to US$1.19 per CVR if certain milestones are achieved.
- The company's shares are expected to be de-listed from the Toronto Stock Exchange on or about September 26, 2025, and from the Nasdaq Capital Market on or about September 25, 2025.
Sep 25, 2025, 6:02 PM
Theratechnologies Receives Final Court Approval for Acquisition by Future Pak
THTX
M&A
Takeover Bid
- Theratechnologies Inc. has received final court approval from the Superior Court of Québec for its previously announced plan of arrangement to be acquired by CB Biotechnology, LLC, an affiliate of Future Pak, LLC.
- This final court approval follows the shareholder approval obtained on September 12, 2025.
- The company anticipates the arrangement will be completed on or about September 25, 2025, subject to the satisfaction of remaining closing conditions.
Sep 17, 2025, 2:10 PM
Theratechnologies Shareholders Approve Acquisition by Future Pak Affiliate
THTX
M&A
Proxy Vote Outcomes
Takeover Bid
- Theratechnologies Inc. shareholders have approved a plan of arrangement for the company to be acquired by CB Biotechnology, LLC, an affiliate of Future Pak, LLC.
- The arrangement resolution was approved by 97.44% of the votes cast by shareholders.
- The proposed acquisition remains subject to customary closing conditions, including a final order by the Superior Court of Québec following a hearing expected on September 16, 2025.
Sep 12, 2025, 6:07 PM
Theratechnologies Shareholders Approve Acquisition by Future Pak
THTX
M&A
Proxy Vote Outcomes
Takeover Bid
- Theratechnologies shareholders have approved the previously announced plan of arrangement to be acquired by CB Biotechnology, LLC, an affiliate of Future Pak, LLC.
- The arrangement resolution received overwhelming support, with 97.44% of votes cast by shareholders approving it.
- The proposed arrangement remains subject to customary closing conditions, including a final order from the Superior Court of Québec, with a hearing anticipated on September 16, 2025.
Sep 12, 2025, 3:23 PM
Quarterly earnings call transcripts for Theratechnologies.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more